Dr Girish Sharma


Amity Institute of Biotechnology
  • Qualifications

    Graduation : B.Sc(Botany)-1988,Delhi University

    Post Graduation : M.Sc(Bioscience)-1991,Jamia Milia Islamia

    Doctorate : Ph.D.(Microbiology)-1997,Jamia Milia Islamia

  • Experience

    25 Aug 2010 - Present
    Amity Institute of Biotechnology

    01 Sep 2003 - 30 Nov 2008
    Post Doctoral Fellow,
    University of Colorado, USA,

    01 Jan 1997 - 01 Jan 2001
    Research Assistant,
    National Research Center,
    New Delhi

    01 Jan 1991 - 31 Dec 1996
    Jamia Milia University,
    New Delhi

  • Current Courses Taught

    Animal Biotechnology

    Basics of Cancer

    Cancer Biology

    Epidemiology and Biostatistics

  • Publications

    Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments ,

    Phytochemicals of nutraceutical importance: their role in health and diseases

    Synergistic growth inhibition of RCC and NSCLC cell lines by sorafenib plus vorinostat and induction of angiogenic genes by ER stress ,
    Journal of Clinical Oncology

    Phytochemicals of Nutraceutical Importance ,
    CAB International (CABI), Nosworthy Way, Wallingford, Oxon, UK

    Global epidemiology of prostate cancer ,
    CRC Press, USA

  • Affiliations

    Indian Association for Cancer Research (IACR), Mumbai, India Since 17 Dec 2012

    Indian Association for Cancer Research (IACR), Mumbai, India Since 17 Dec 2012

  • Activities

    Chairperson: Scientific session IV- Inflammation in Cancer and other Diseases at UGC SAP sponsored National Conference on “Chronic Inflammatory Disorders” Organized by Department of Biochemistry, Faculty of Science & Department of Medical Biochemistry, HIMSR & HAHC Hospital, held at Jamia Hamdard, New Delhi, India February 13-15, 2014.